Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

• Auteurs principaux: Willem D. F. Venter (Auteur), Mohammed Majam (Auteur), Godspower Akpomiemie (Auteur), Natasha Arulappan (Auteur), Michelle Moorhouse (Auteur), Nonkululeko Mashabane (Auteur), Matthew F. Chersich (Auteur)
• Format: Livre
• Publié: BMC, 2017-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Background Screening for renal, hepatic and haematological disorders complicates the initiation of current first-line antiretroviral therapy (ART). Each additional test done adds substantial costs, both through direct laboratory expenses, but also by increasing the burden on health workers...